Integral Diagnostics Stock

Integral Diagnostics Liabilities 2024

Integral Diagnostics Liabilities

465.96 M AUD

Ticker

IDX.AX

ISIN

AU000000IDX2

In 2024, Integral Diagnostics's total liabilities amounted to 465.96 M AUD, a 6.93% difference from the 435.77 M AUD total liabilities in the previous year.

Integral Diagnostics Aktienanalyse

What does Integral Diagnostics do?

Integral Diagnostics Ltd is an Australian company that has been providing medical imaging services for over 25 years. The company was founded in 1994 by Dr. Ian Kadish and a team of radiologists in Perth, Western Australia, offering radiology services to local clinics and hospitals. Over the years, Integral Diagnostics has expanded its services to provide imaging services nationwide. The business model of Integral Diagnostics is to deliver medical imaging to enable doctors and their patients to have a fast and accurate diagnosis. The company offers imaging services for a variety of medical specialties, including radiology, cardiology, obstetrics and gynecology, and neurology. They operate over 49 locations in Australia, many of which are in rural areas where access to medical care may be limited. Integral Diagnostics offers a wide range of products based on medical imaging. These include X-rays, mammography, ultrasound, CT scans, MRI scans, PET scans, and bone density scans. The company takes pride in being one of the few Australian medical imaging companies to offer a complete range of imaging services. Their services are conducted by qualified radiologists specialized in interpreting medical images. Integral Diagnostics also operates clinics for performing diagnostic and therapeutic procedures such as biopsies, drainages, and injections. These procedures are carried out by highly qualified radiologists to provide patients with faster and more accurate diagnoses. Integral Diagnostics is committed to quality assurance and has a comprehensive quality management system that is annually reviewed by independent auditors. The company is accredited by both the Australian Medical Association and the Australian National Accreditation Scheme (NATA). These accreditations recognize the high standards that Integral Diagnostics sets for delivering medical imaging services. One of Integral Diagnostics' recent activities is their use of artificial intelligence (AI) in image interpretation. The company has partnered with MaxQ AI, a leading provider of AI solutions for medical imaging. Through this partnership, Integral Diagnostics doctors can utilize the latest AI tools to improve their patients' diagnoses. Integral Diagnostics is a strong advocate for social justice and is dedicated to supporting disadvantaged communities in Australia. The company has partnered with nonprofit organizations such as the National Breast Cancer Foundation, The Smith Family, and the Friendship Foundation. Overall, Integral Diagnostics has undergone impressive growth over the past 25 years and is now a leading Australian medical imaging company. With a wide range of imaging services and a strong focus on quality and social responsibility, the company is well-positioned to continue its success in the future. Integral Diagnostics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Integral Diagnostics's Liabilities

Integral Diagnostics's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Integral Diagnostics's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Integral Diagnostics's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Integral Diagnostics's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Integral Diagnostics’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Integral Diagnostics stock

What is the level of liabilities of Integral Diagnostics this year?

Integral Diagnostics has a debt balance of 465.96 M AUD this year.

What were the liabilities of Integral Diagnostics compared to the previous year?

The liabilities of Integral Diagnostics have increased by 6.93% increased compared to the previous year.

What are the consequences of high debt for investors of Integral Diagnostics?

High liabilities can pose a risk for investors of Integral Diagnostics, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Integral Diagnostics?

Low liabilities mean that Integral Diagnostics has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Integral Diagnostics affect the company?

An increase in liabilities of Integral Diagnostics can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Integral Diagnostics affect the company?

A decrease in the liabilities of Integral Diagnostics can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Integral Diagnostics?

Some factors that can influence the liabilities of Integral Diagnostics include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Integral Diagnostics so important for investors?

The liabilities of Integral Diagnostics are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Integral Diagnostics take to modify the liabilities?

To change its liabilities, Integral Diagnostics can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Integral Diagnostics pay?

Over the past 12 months, Integral Diagnostics paid a dividend of 0.09 AUD . This corresponds to a dividend yield of about 3.32 %. For the coming 12 months, Integral Diagnostics is expected to pay a dividend of 0.08 AUD.

What is the dividend yield of Integral Diagnostics?

The current dividend yield of Integral Diagnostics is 3.32 %.

When does Integral Diagnostics pay dividends?

Integral Diagnostics pays a quarterly dividend. This is distributed in the months of April, September, March, September.

How secure is the dividend of Integral Diagnostics?

Integral Diagnostics paid dividends every year for the past 14 years.

What is the dividend of Integral Diagnostics?

For the upcoming 12 months, dividends amounting to 0.08 AUD are expected. This corresponds to a dividend yield of 3.28 %.

In which sector is Integral Diagnostics located?

Integral Diagnostics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Integral Diagnostics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Integral Diagnostics from 10/3/2024 amounting to 0.047 AUD, you needed to have the stock in your portfolio before the ex-date on 8/30/2024.

When did Integral Diagnostics pay the last dividend?

The last dividend was paid out on 10/3/2024.

What was the dividend of Integral Diagnostics in the year 2023?

In the year 2023, Integral Diagnostics distributed 0.1 AUD as dividends.

In which currency does Integral Diagnostics pay out the dividend?

The dividends of Integral Diagnostics are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Integral Diagnostics

Our stock analysis for Integral Diagnostics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Integral Diagnostics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.